Table 6.
Concluding remarks on technical steps for advancement flap on perianal fistulizing Crohn’s disease
| Step | Conclusions |
|---|---|
| Patient selection | On optimized medical treatment (biological therapy) |
| No active proctitis, minimal luminal inflammation | |
| No or minimal anal canal stenosis (anal fistulas) | |
| Timing | Fistula adequately drained with no signs of inflammation |
| No major cephalic extensions, secondary tracts, or cavities of granulation tissue | |
| Wait for the medical treatment to take effect | |
| Intraoperative remarks | Thorough dissection of a tension-free flap and preparation of a landing zone may be challenging—discontinue if significant fibrosis is present beneath the mucosa |
| Precise eradication of the IO and proper closure of the fistula tract | |
| Minimize dead space | |
| Consider core-out of the EO and fistula tract up to the sphincter | |
| Postoperative remarks | Plan the first follow-up in 3–4 months—if no signs of infection, re-evaluate clinical healing 6–12 months postoperatively |
| Optimal medical treatment continued | |
| If complete clinical healing at 12 months, consider assessing radiological healing on MRI at 18 months before reducing medication |
IO, internal orifice; EO, external orifice; MRI, magnetic resonance imaging